Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 07:00 save search
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
Published: 2023-03-13 (Crawled : 07:00) - globenewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
PRVB | $24.98 0.08% 9.1M
|
Health Technology
|
| O: 241.08%
H: 0.62%
C: 0.08%
treatment acquire diabetes sanofi
Clinical Trial Approval For The Company's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines Jiangsu Recbio Technology Co., Ltd. is pleased to announce that, the Group has recently...
Published: 2022-12-19 (Crawled : 07:00) - biospace.com/
MDGL M | $233.0 0.7% 210K
|
Health Technology
|
| O: 219.37%
H: 0.0%
C: 0.0%
rec610 vaccine technology trial approval group
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
Published: 2023-11-01 (Crawled : 07:00) - globenewswire.com
CLLS | $2.6 -0.38% 72K
|
Health Technology
|
| O: 179.38%
H: 10.33%
C: -2.58%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: 0.03%
H: 1.17%
C: 0.84%
collaboration
GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr
Published: 2022-09-22 (Crawled : 07:00) - biospace.com/
GSK | $40.035 -1.15% 1.5M
|
Health Technology
|
| O: -0.71%
H: 2.03%
C: 1.52%
SPRO | $1.57 -4.27% 88K
|
Health Technology
|
| O: 148.27%
H: 55.88%
C: 7.84%
license therapeutics agreement
Verona Pharma Announces Ensifentrine Meets Primary Endpoint in Phase 3 ENHANCE-2 Trial for COPD
Published: 2022-08-09 (Crawled : 07:00) - biospace.com/
VRNA | $16.02 1.39% 270K
|
Health Technology
|
| O: 101.29%
H: 5.0%
C: -28.31%
pharma trial
Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Published: 2024-03-19 (Crawled : 07:00) - prnewswire.com
FUSN | $21.25 -0.14% 370K
|
Health Technology
|
| O: 96.99%
H: 1.19%
C: 1.05%
cancer treat pharmaceuticals acquired
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
Published: 2020-12-15 (Crawled : 07:00) - globenewswire.com
BNR | $0.7264 -9.19% 27K
|
Health Services
|
| O: -1.1%
H: 1.72%
C: 1.15%
OCX | $2.65 4.74% 130K
|
Health Technology
|
| O: 62.74%
H: 1.74%
C: -26.67%
license risk cancer china test lung cancer
Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
Published: 2023-12-26 (Crawled : 07:00) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 54.84%
H: 0.0%
C: 0.0%
biotechnologies cell acquired therapy
Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
Published: 2023-12-12 (Crawled : 07:00) - globenewswire.com
ICVX | $15.31 -0.65% 9.3M
|
|
| O: 53.48%
H: 1.02%
C: 0.26%
candidate vaccine positive topline rsv results
Metal Detector Market Size to Grow by USD 160.56 Million | By Product (walk-through, handheld, and ground search), Geography, and Application - Global Industry Analysis and Forecast 2020-2024
Published: 2022-04-28 (Crawled : 07:00) - prnewswire.com
VSYM | $0.0001
|
Manufacturing
|
| O: 50.0%
H: 0.0%
C: -33.33%
application market
Dierks Bentley announced for SPAC in July – Nippertown
Published: 2024-02-12 (Crawled : 07:00) - spacfeed.com
BLTH | $0.6 1K
|
Manufacturing
|
| O: 50.0%
H: 0.0%
C: 0.0%
spac
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
Published: 2022-06-09 (Crawled : 07:00) - igcinc.us
IGC 4 | $0.4988 13.57% 4.5M
|
Health Technology
|
| O: 48.37%
H: 14.13%
C: -1.3%
patent
IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi
Published: 2022-03-29 (Crawled : 07:00) - globenewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
IGMS | $9.06 -3.72% 54K
|
Health Technology
|
| O: 42.23%
H: 68.76%
C: 38.32%
conference collaboration
CooTek Announces Fourth Quarter and Full Year 2021 Unaudited Results
Published: 2022-03-15 (Crawled : 07:00) - prnewswire.com
CTK | $0.9111 0.0%
|
Technology Services
|
| O: 41.99%
H: 6.43%
C: -3.57%
ces results
CooTek Announces Share Purchase by Senior Management
Published: 2022-03-15 (Crawled : 07:00) - prnewswire.com
CTK | $0.9111 0.0%
|
Technology Services
|
| O: 41.99%
H: 6.43%
C: -3.57%
ces
Celyad Oncology Announces $32.5 Million Private Placement with Fortress Investment Group
Published: 2021-12-03 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 37.64%
H: 8.57%
C: -4.08%
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
Published: 2022-12-23 (Crawled : 07:00) - globenewswire.com
DBVT | $0.699 0.58% 4.4K
|
Health Technology
|
| O: 31.36%
H: 0.0%
C: -7.1%
fda lifted clinical hold
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
VYGR | $8.11 -1.58% 130K
|
Health Technology
|
| O: 31.15%
H: 19.58%
C: 9.17%
trace novartis aav capsids gene therapy program license therapeutics therapy
VEON Holdings B.V. reiterates currency election on its ruble-denominated notes
Published: 2022-03-18 (Crawled : 07:00) - prnewswire.com
VEON | $22.59 -4.36% 2K
|
Communications
|
| O: 30.37%
H: 33.76%
C: 12.07%
GeoTraq, a Wholly Owned Subsidiary of SPYR, Launches Revolutionary Miniature Tracking Device
Published: 2023-07-17 (Crawled : 07:00) - globenewswire.com
SPYR | $0.0001 250K
|
Accommodation and Food Services
|
| O: 28.57%
H: 11.11%
C: -5.56%
device wholly
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.